Blogarama: The Oldest Blog Directory

Incyte Corporation (INCY – Free Report) reported fourth-quarter earnings of 15 cents beating the Zacks Consensus Estimate of 14 cents. Incyte had reported e… Read More

Olumiant has recently been approved by the FDA for the treatment of Rheumatoid Arthritis. This chronic inflammatory disorder affects joints, but can progress to damage several body systems… Read More

stevepb / Pixabay The News: Galapagos NV (Mechelen BEL) and Gilead Sciences Inc. (Foster City CA) have reported positive results from a Phase 3 trial testing Galapagos’s lead drug cand… Read More

Rabenspiegel / Pixabay Although usually thought of as a well-deserved respite from governmental rulings, the US Food and Drug Administration seized on Thanksgiving week as a demonstration of… Read More

The administrative building of the National Institutes of Health. | J. Scott Applewhite/AP Photo Coronavirus treatment guidelines issued by a government panel conclude there is not enoug… Read More

The National Institute of Allergy and Infectious Diseases — the agency run by Anthony Fauci — has launched the first randomized, controlled trial of remdesivir, enlisting about… Read More

Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a potential treatment for COVID-19 in a Phase III study. Indianapolis-based Eli Lilly said the latest study will compl… Read More

Eli Lilly is set to begin a Phase III study to evaluate its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a treatment for COVID-19. The drug has shown promising effects in rheumatoid arthrit… Read More

ABD’li ilaç şirketi Eli Lily, remdesivir ile kombinasyon halinde verilen Olumiant markalı ilacı Baricitinib’in kritik Covid-19 hastalarının iyile… Read More

As one of only two treatments currently approved in the US for the treatment of COVID-19, Gilead’s remdesivir could soon be joined by Eli Lilly’s arthritis medication Olumiant (b… Read More

Worldwide, more than 43 million people have been infected by SARS CoV-2 and more than 1.1 million people have lost their lives in the battle against COVID-19. There are no drugs or vaccines… Read More

Una mujer que contrajo coronavirus arriba a un hospital de la ciudad de Nueva York (EFE/Justin Lane/Archivo) (EFEI0023/)Las autoridades sanitarias de Estados Unidos aprobaron este jueves el… Read More

The Food and Drug Administration (FDA) has announced the emergency use authorization (EUA) for baricitinib (Olumiant), in combination with remdesivir (Veklury), for hospitalized COVID-19 pat… Read More

Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.On Friday, a World… Read More

Mumbai: Hyderabad-based Natco Pharma is examining the possibility of filing a compulsory licensing application for a generic version of Eli Lilly's Covid-19 drug baricitinib, potentially tri… Read More

Ivermectin a medication used to treat parasitic infestations such  head lice, scabies, river blindness, strongyloidiasis, trichuriasis, ascariasis, and lymphatic filariasis  has s… Read More

09 Endocrine drugs Eli Lilly’s Lyumjev is a fast-acting insulin used to improve blood glucose control in adults with type 1 and type 2 diabetes. It was approved in the European Unio… Read More

13 Anti-tumor drugs Trastuzumab deruxtecan (Enhertu), an antibody drug conjugate (ADC) developed by Japan’s Daiichi Sankyo and authorized by AstraZeneca for co-development and comme… Read More

The World Health Organization (WHO) has backed the use of interleukin (IL)-6 receptor blockers as a COVID-19 treatment for severely or critically ill patients with the infection, alongside c… Read More

The World Health Organization (WHO) has backed the use of interleukin (IL)-6 receptor blockers as a COVID-19 treatment for severely or critically ill patients with the infection, alongside c… Read More

The Covid-19 pandemic started almost two years ago, and since then, health providers and organizations have studied and used several treatments and vaccines to help save people’s lives… Read More

A OMS emitiu uma “forte recomendação” para baricitinibe, em combinação com corticosteroides, no tratamento de pacientes com COVID-19 grave ou cr&iacut… Read More

The US Food and Drug Administration (FDA) has approved not one, but two, new orally administered drugs for the treatment of moderate to severe eczema (atopic dermatitis), which include AbbVi… Read More

Published by AFP Alopecia, which is driven by the immune system attacking hair follicles, has recently come to the fore through high profile cases including Hollywood actress Jada Pinke… Read More

The FDA has followed highly promising results from trials demonstrating the hair regrowth potential of a common arthritis drug with a landmark approval, giving baricitinib the green light as… Read More

Eli Lilly’s Olumiant (baricitinib) has won US Food and Drug Administration (FDA) approval as the first systemic treatment for severe alopecia areata (AA), an autoimmune disorder that l… Read More

 Mayo Clinic [This is my analysis of this information, and my opinions, not medical advice, consult your physician ALWAYS… J. Ramirez] COVID-19: Advice, updates and vaccine optio… Read More

In this episode, Ayesha and the team talked about the FDA approval of Eli Lilly’s JAK inhibitor Olumiant for the treatment of alopecia areata, also commonly just known as alopecia. The… Read More

Biopharmaceutical company Incyte received approval from the US Food and Drug Administration (FDA) for Opzelura (ruxolitinib) cream 1.5 percent for the topical treatment of nonsegmental vitil… Read More

On June 13, 2022, the US Food and Drug Administration (FDA) announced that Olumiant (baricitinib) has been approved for the treatment of adult patients with severe alopecia areata. When clin… Read More

The development program for at least one of the of the Gastroenterology CRO agents that I’m aware of was stop, which I’m not sure why. There’s not a very robust active pipe… Read More

In 2001, the FDA approved Imatinib, the first drug to be developed by targeting a specific protein kinase and the first molecularly targeted drug to fight cancer. It was considered a milesto… Read More

It’s extremely natural to have hairs fall out of your head. In fact, most people shed anywhere from 50 to 100 hairs a day.But when your hair is falling out in patches, it could mean yo… Read More

In 1986, the National Alopecia Areata Foundation (NAAF) declared September Alopecia Awareness Month.  Throughout the month, public service and fundraising campaigns will generate aware… Read More

On a cloudy Christmas morning last year, a rocket carrying the most powerful space telescope ever built blasted off from a launchpad in French Guiana. After reaching its destination in space… Read More

Baricitinib is a targeted therapy drug. The medicine is sold under the brand name Olumiant. It belongs to the category of Janus kinase inhibitors. This medicine is approved by the US FDA for… Read More

Eli Lilly and Company (NYSE: LLY) discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix… Read More

Overview Sinus infections and COVID-19 are respiratory conditions that can cause similar symptoms, leading to confusion and concern. But it is imperative to understand the critical differ… Read More

David Ricks, CEO, Eli Lilly Scott Mlyn | CNBC Eli Lilly on Tuesday said it struck a $2.4 billion deal to acquire Dice Therapeutics in a bid to bulk up its treatment portfolio for im… Read More

Pfizer’s alopecia JAK inhibitor Litfulo (ritlecitinib) has become its fourth US Food and Drug Administration (FDA) approved product in the past several weeks. Litfulo is entering the a… Read More

This episode features an interview with Dr. William Williams, CEO of BriaCell Therapeutics, a biotech company based in Philadelphia that is dedicated to developing novel immunotherapies to f… Read More

سنتعرف حول علاج روماتيزم المفا… Read More

Healthcare companies are always on the lookout to improve outcomes in the healthcare system and consolidate the healthcare industry. Healthcare providers offer essential services and game-ch… Read More

Global medicine market — using invoice price levels — should be able to compound in the range of 3%-6% through 2025, touching ~$1.6 trillion in total market size in 2025. This fi… Read More